A lab working on next-generation treatments for ovarian and pancreatic cancer is no longer able to continue what a head professor says is “promising research.”

The National Institutes of Health is the largest public funder of biomedical research in the world, but under the Trump administration, NIH is freezing funding to several universities, including Northwestern. One of the projects being delayed is cutting-edge research on treatments for ovarian and pancreatic cancer… Click here to listen to the interview.